Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis in New Zealand Māori.
Impact of a 10-week individualized exercise program on physical function and fatigue of people with multiple sclerosis: a pilot study.
Pilot Trial of a Social Cognitive Theory-Based Physical Activity Intervention Delivered by Non-Supervised Technology in Persons With Multiple Sclerosis.
Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 - 2014).
Determinants of sexual dysfunction in women with multiple sclerosis.
Comorbidities at multiple sclerosis diagnosis.
Is the 'liberation procedure' for multiple sclerosis really liberating?
Menopause in multiple sclerosis: therapeutic considerations.
Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy.
Protective Autoimmunity: A Unifying Model for the Immune Network Involved in CNS Repair.
Regulatory T-Cells in Chronic Lymphocytic Leukemia and Autoimmune Diseases.
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients.
Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction.
Testosterone Depletion Increases the Susceptibility of Brain Tissue to Oxidative Damage in a Restraint Stress Mouse Model.
Valuing the Endangered Species Antirrhinum lopesianum: Neuroprotective Activities and Strategies for in vitro Plant Propagation.
Quantitative MRI demonstrates abnormality of the fornix and cingulum in multiple sclerosis.
Timing of cigarette smoking as a risk factor for multiple sclerosis.
Walking function in clinical monitoring of multiple sclerosis by telemedicine.
Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors.
CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
IL-17F but not IL-17A gene polymorphism confers risk to multiple sclerosis in a Chinese Han population.
Paraneoplastic neuromyelitis optica associated with ANNA-1 antibodies in invasive thymoma.
Pages
« first
‹ previous
…
477
478
479
480
481
482
483
484
485
…
next ›
last »